Bengaluru (Karnataka) [India], September 27: In today’s global economy, companies aren’t just seeking accountants; they’re searching for strategic leaders who can analyze data, shape financial decisions, and guide
Learn. Lead. Excel. With Miles Education by Your Side. Bengaluru (Karnataka) [India], September 27: If you are dreaming of a future where you lead in finance, the CMA
Unlock potential. Build expertise. Lead with numbers. Bengaluru (Karnataka) [India], September 27: In today’s business landscape, where financial intelligence drives corporate decisions, the CMA course has emerged as
New Delhi [India], September 27: In a significant development for India’s animal health sector, veterinary vaccine manufacturers have come together to announce the formation of the Veterinary Vaccine
New Delhi [India], September 25: Yet another time, the excellence attained from high accomplishments from leading and renowned experts in electrical power distribution came to the limelight from
Mumbai (Maharashtra) [India], September 25: Connplex Cinemas Limited (NSE- CONNPLEX | INE0EAS01014), a fast-growing entertainment company redefining movie experiences in India through premium theatres, advanced technology, and cinema management, has announced the opening of a new
Hyderabad (Telangana) [India], September 25: Fertility preservation is no longer a subject confined to medical textbooks and oncology wards—it is now part of mainstream conversations among India’s urban,
New Delhi [India], September 25: SoftTech Engineers is set to host the NIRMANA 100 – Innovation Convergence on September 25, 2025, at SoftTech Towers, Baner, Pune. The event
Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s
Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar